No Data
No Data
No Data
Baize Healthcare earns 350 million yuan a year but is not yet profitable. It says it is supported by Beijing Medicine and Beijing Oncology experts
On April 26, Baize Healthcare Group (hereinafter referred to as “Baize Healthcare”) submitted a prospectus on the Hong Kong Stock Exchange, with CMB International as the sole sponsor. According to Ruizai Financial Research, Baize Medical is an oncology medical group that invests in and provides medical-related services. As of the last practical date, Baize Medical has operated and managed eight hospitals in Beijing, Tianjin, Shanxi, Anhui and Henan provinces through direct equity ownership in six private for-profit hospitals and management rights for two private non-profit hospitals, focusing on providing full-cycle oncology medical services. In terms of performance, from 2021 to 2023, Baize Healthcare's revenue score
Baize Medical, a private cancer hospital, went public in Hong Kong, and CMB International was the sole sponsor
① Baize Medical submitted an IPO application for Hong Kong stocks. What are the highlights of the company's business? ② The private oncology industry is growing rapidly. What is the room for future growth?
No Data